Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTs071260054Recruiting
Randomised, open-label trial in Insomnia comparing Vornorexant arm with Ramelteon arm (2 arms). Primary endpoint: Primary efficacy endpoint. Started Sep 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTs071260054.